| Abstract:Objective To investigate the prevalence and influencing factors of cognitive impairment in hospitalized elderly patients with chronic diseases,and to establish and validate a risk prediction model,so as to provide a reference for reducing cognitive impairment in this population.Methods From March 2025 to August 2025,a total of 752 elderly inpatients with chronic diseases were enrolled from the First Affiliated Hospital of Guangxi Medical University,the First Affiliated Hospital of Wannan Medical College,and Wuhu Second People’s Hospital using a simple random sampling method.All participants completed a set of questionnaires,including a general demographic questionnaire,the Ascertain Dementia 8 (AD8) for cognitive impairment,the Oral Frailty Index8 (OFI8),and the Clinical Health Evaluation and Scoring Scale (CHEES).Spearman correlation analysis and binary logistic regression were performed to explore the correlates and influencing factors of cognitive impairment in elderly inpatients with chronic diseases.Results Among the 752 patients,the median (interquartile range) scores were 2.00(1.00,5.00) for AD8,5.00 (2.00,8.00) for OFI-8,and 47.00 (41.00,54.00) for CHEES.The prevalence of cognitive impairment was 49.9%.Cognitive impairment was positively correlated with oral frailty (r=0.584,P<0.001) and negatively correlated with clinical physiological resilience (r=-0.529,P<0.001).Logistic regression showed that age,duration of chronic diseases,and oral frailty were risk factors; while marital status,high education level,and good clinical physiological resilience were protective factors (all P<0.05).The prediction model showed good calibration.The area under the ROC curve was 0.857 (95%CI:0.826–0.887),with a sensitivity of 0.906 and specificity of 0.627,indicating favorable clinical applicability and practicability.Conclusion The prevalence of cognitive impairment is high in hospitalized elderly patients with chronic diseases.Medical staff can implement targeted interventions according to the influencing factors to improve cognitive function in these patients. |